Carregant...
Inhibitor Development against p7 Channel in Hepatitis C Virus
Hepatitis C Virus (HCV) is the key cause of chronic and severe liver diseases. The recent direct-acting antiviral agents have shown the clinical success on HCV-related diseases, but the rapid HCV mutations of the virus highlight the sustaining necessity to develop new drugs. p7, the viroporin protei...
Guardat en:
| Publicat a: | Molecules |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7961618/ https://ncbi.nlm.nih.gov/pubmed/33802584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26051350 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|